TBio-6517

· Turnstone Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TBio-6517, covering 2025-04-23 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors [Phase 1]